Is SINO or JNJ a better dividend investment in 2026?

SINO currently yields 47.73% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: SINO offers higher current income.

What is the dividend yield difference between SINO and JNJ?

SINO has a forward dividend yield of 47.73% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 45.60 percentage points.

Home › Compare › SINO vs JNJ

SINO vs JNJ: Dividend Comparison 2026

SINO yields 47.73% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SINO wins by $320.0K in total portfolio value

INVESTMENT

TIME HORIZON10 years

SINO

● Live price

47.73%

Share price

$4.19

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$350.2K

Annual income

$68,392.13

Full SINO calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — SINO vs JNJ

📍 SINO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SINO	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SINO + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SINO pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SINO

Annual income on $10K today (after 15% tax)

$4,057.28/yr

After 10yr DRIP, annual income (after tax)

$58,133.31/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, SINO beats the other by $54,147.32/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SINO + JNJ for your $10,000?

SINO: 50%JNJ: 50%

100% JNJ50/50100% SINO

Portfolio after 10yr

$190.3K

Annual income

$36,540.76/yr

Blended yield

19.21%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SINO

No analyst data

Altman Z

-4.1

Piotroski

0/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SINO buys

JNJ buys

Politician	Chamber	Ticker	Type	Amount	Date
Thomas H. Kean	🏢 House	$JNJ	▼ Sell	$15,001 - $50,000	2026-01-23
Julie Johnson	🏢 House	$JNJ	▼ Sell	$1,001 - $15,000	2025-12-18
Lloyd Doggett	🏢 House	$JNJ	▲ Buy	$1,001 - $15,000	2025-12-09
Thomas H. Kean	🏢 House	$JNJ	▼ Sell	$15,001 - $50,000	2025-11-20
Julie Johnson	🏢 House	$JNJ	▼ Sell	$1,001 - $15,000	2025-11-13
Rich McCormick	🏢 House	$JNJ	▲ Buy	$1,001 - $15,000	2025-11-05
Ro Khanna	🏢 House	$JNJ	▲ Buy	$1,001 - $15,000	2025-10-30
Ro Khanna	🏢 House	$JNJ	▲ Buy	$1,001 - $15,000	2025-10-30
Ro Khanna	🏢 House	$JNJ	▲ Buy	$1,001 - $15,000	2025-10-30
Jared Moskowitz	🏢 House	$JNJ	▼ Sell	$1,001 - $15,000	2025-10-10

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSINOJNJ

Forward yield	47.73% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$350.2K ✓	$30.3K
Annual income after 10y	$68,392.13 ✓	$4,689.40
Total dividends collected	$276.4K ✓	$15.4K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: SINO vs JNJ ($10,000, DRIP)

Year	SINO Portfolio	SINO Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$15,473	$4,773.27	$10,592	$272.30	+$4.9K → SINO
2	$23,459	$6,902.63	$11,289	$357.73	+$12.2K → SINO
3	$34,882	$9,780.44	$12,123	$472.89	+$22.8K → SINO
4	$50,915	$13,591.30	$13,141	$629.86	+$37.8K → SINO
5	$73,019	$18,540.58	$14,408	$846.81	+$58.6K → SINO
6	$102,981	$24,850.45	$16,021	$1,151.60	+$87.0K → SINO
7	$142,944	$32,754.46	$18,122	$1,588.22	+$124.8K → SINO
8	$195,441	$42,490.89	$20,930	$2,228.20	+$174.5K → SINO
9	$263,417	$54,295.23	$24,792	$3,191.91	+$238.6K → SINO
10	$350,249	$68,392.13	$30,274	$4,689.40	+$320.0K → SINO

SINO vs JNJ: Complete Analysis 2026

SINO — Stock

Singularity Future Technology Ltd. provides shipping and freight logistics integrated solutions in the People's Republic of China and the United States. It operates through Shipping Agency and Management Services and Freight Logistics Services segments. The company offers shipping agency services, such as loading/discharging and protective agency. The company was formerly known as Sino-Global Shipping America, Ltd. and changed its name to Singularity Future Technology Ltd. in January 2022. Singularity Future Technology Ltd. was incorporated in 2001 and is headquartered in Great Neck, New York.

Full SINO Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this SINO vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SINO vs SCHD SINO vs JEPI SINO vs O SINO vs KO SINO vs MAIN SINO vs ABBV SINO vs MRK SINO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.